What is TAS-116 used for?

TAS-116 is being researched for the treatment of gastrointestinal stromal tumors and other neoplasms.

Is TAS-116 an approved drug?

No, TAS-116 is currently a research compound in clinical trial phases and is not yet approved for general use.

What kind of medicine is TAS-116?

TAS-116 is categorized as a small molecule research compound.

Are there known side effects for TAS-116?

There is no specific information provided regarding common or serious side effects in the current data.

Can TAS-116 be used for cancer treatment?

It is being studied for its potential to treat neoplasms, which include various types of tumors.

Pimitespib | CAS 1260533-36-5 | NVVPMZUGELHVMH

Loading compound...

Small molecule research compound

TAS-116 is a small molecule currently being studied in clinical research. It is being investigated for its potential use in treating neoplasms (growths or tumors) and gastrointestinal stromal tumors.

How it worksTAS-116 is a small molecule currently in the research phase, meaning its exact way of working in the body is still being studied in clinical trials.

Used for

Gastrointestinal stromal tumorsNeoplasms (tumors or growths)

Conditions

Gastrointestinal stromal tumorsNeoplasms

Class

Small moleculeSmall molecule research compoundGastrointestinal

How to take

This substance is currently in Phase 1 and Phase 2 clinical development and is not an approved medication for general use.

Talk to your doctor

Questions to ask

·Is TAS-116 part of a clinical trial I can join?
·What are the potential risks of TAS-116 for treating neoplasms?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)